OptiRTP Meets New Zealand’s Ambassador-Designate to the United States
Left to right: Bogdan Anich (Founder & CTO, OptiRTP), Chris Seed (New Zealand’s Ambassador-Designate to the United States), Jon Doherty (CEO, OptiRTP)
OptiRTP CEO Jon Doherty and Founder & CTO Bogdan Anich attended a networking function with Chris Seed, New Zealand’s Ambassador-Designate to the United States, on 4 December 2025.
The event was hosted by the Director of Ministry of Foreign Affairs and Trade (Auckland), Ms Rachel Maidment, in collaboration with the NZUS Council and AmCham NZ. It was held at the MFAT Auckland Office on Quay Street.
Ambassador-Designate Seed, who will take up his post in Washington, D.C. in early 2026, met with representatives from select New Zealand companies that are already operating in the U.S. or preparing for U.S. market entry.
“Anything I can do to help.”
OptiRTP is planning its U.S. expansion in 2026, with site selection visits to several states scheduled for Q1.
About OptiRTP
OptiRTP is a New Zealand health-technology company developing Optimum Bio Sound Therapy (OBST), a neuromodulation platform registered as an FDA Class I medical device. The platform has delivered over 200,000 therapy hours to more than 1,100 users. www.optirtp.com
